Puma Biotechnology | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Daiichi Sankyo JPY 1.62T 958M 2025-03
Exelixis USD 2.13B 113.18M 2025-04
Gilead Sciences USD 19.33B 856M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Incyte USD 3.67B 219.94M 2025-03
MacroGenics USD 116.06M 4.01M 2024-12
Moderna USD 10.07B 835M 2025-03
Novartis USD 44.05B 605M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
PTC Therapeutics USD -185760000 912.31M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Takeda JPY 6.94T 483.19B 2025-03
TG Therapeutics USD 222.36M 30.21M 2024-12
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Puma Biotechnology Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.